ARTO Trial: Overall Survival Analysis from a Randomized Phase II Trial Testing the Benefit of Adding Stereotactic Body Radiotherapy to Abiraterone Acetate in Patients with Oligometastatic Castrate-Resistant Prostate Cancer.
JOURNAL OF CLINICAL ONCOLOGY（2024）
Key words
261-492-3532-2370-7650-2700,261-137-3222-3876-5567,283-2494-5577-2829,298-145-222-184-1022-9124,3282-270-434-2806,261-265,162,162
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined